Persistent postpartum hypertension in preeclampsia with severe feature Preeclampsia, Postpartum period, Hypertension
Conditions
Interventions
Furosemide dose 20 mg oral once 3 days
half tab of Furosemide 40 mg,Placebo half tab oral once 3 days
Experimental Drug,Placebo Comparator Drug
Furosemide,Placebo
Sponsors
None listed
Eligibility
Sex/Gender
Female
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: Women who's 15 years old or more with preeclampsia with severe features who was undergone termination of pregnancy at 24 weeks' gestation or more
Exclusion criteria
Exclusion criteria: 1.pre-existing hypertension or taking antihypertensive medication 2.hypokalemia 3.history used of diuretic drug 4.unstable vital signs 5.allergy to furosemide or sulfonylurea 6.severe postpartum complication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure at 72 hours postpartum 72 hours postpartum Blood pressure measurement in mmHg,Persistent hypertension at 72 hours postpartum 72 hours postpartum systolic blood pressure 140 mmHg or more OR diastolic blood pressure 90 mmHg or more | — |
Secondary
| Measure | Time frame |
|---|---|
| the use of antihypertensive medication at hospital discharge patient's antihypertensive drug at hospital discharge,Milk ejection performance 3 days postpartum milk ejection score (0-4),Hospital stay after termination at hospital discharge number of days,Potassium level 6 hours after 2nd tab administration blood chemistry lab,creatinine level 6 hours after 2nd tab administration blood chemistry lab | — |
Countries
Thailand
Contacts
Public ContactChayanid Detwongya
Maharat Nakhon Ratchasima Hospital
Outcome results
None listed